Natco Pharma receives EIR from USFDA for Kothur unit

20 Jul 2017 Evaluate

Natco Pharma has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug formulations facility at Kothur Unit, Telangana, India, during the period Jan 16th - 24th, 2017. This Kothur formulation facility predominantly caters to regulated international markets, including USA.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.



Natco Pharma Share Price

811.05 -20.70 (-2.49%)
27-Jan-2026 12:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.00
Dr. Reddys Lab 1239.85
Cipla 1314.30
Zydus Lifesciences 889.50
Lupin 2139.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×